CC vs. ASIX, CE, DD, DOW, EMN, HUN, NTR, OLN, TROX, and AXTA
Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include AdvanSix (ASIX), Celanese (CE), DuPont de Nemours (DD), DOW (DOW), Eastman Chemical (EMN), Huntsman (HUN), Nutrien (NTR), Olin (OLN), Tronox (TROX), and Axalta Coating Systems (AXTA). These companies are all part of the "basic materials" sector.
Chemours vs. Its Competitors
Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends and analyst recommendations.
Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.8%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.6%. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AdvanSix pays out 20.5% of its earnings in the form of a dividend. AdvanSix has increased its dividend for 2 consecutive years.
Chemours has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.
Chemours currently has a consensus price target of $17.33, indicating a potential upside of 39.56%. AdvanSix has a consensus price target of $33.50, indicating a potential upside of 37.18%. Given Chemours' higher probable upside, equities analysts clearly believe Chemours is more favorable than AdvanSix.
AdvanSix has a net margin of 5.45% compared to Chemours' net margin of 0.54%. Chemours' return on equity of 23.82% beat AdvanSix's return on equity.
In the previous week, Chemours had 2 more articles in the media than AdvanSix. MarketBeat recorded 7 mentions for Chemours and 5 mentions for AdvanSix. AdvanSix's average media sentiment score of 0.62 beat Chemours' score of 0.56 indicating that AdvanSix is being referred to more favorably in the news media.
76.3% of Chemours shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 0.3% of Chemours shares are owned by company insiders. Comparatively, 5.6% of AdvanSix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Chemours has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500.
Summary
AdvanSix beats Chemours on 10 of the 19 factors compared between the two stocks.
Get Chemours News Delivered to You Automatically
Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Chemours Competitors List
Related Companies and Tools
This page (NYSE:CC) was last updated on 7/8/2025 by MarketBeat.com Staff